Poietis is a health-tech company based in France, founded in 2014, with the slogan "Make tissues real." The company specializes in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and collaborates with leading clinicians to develop advanced therapies. The last recorded investment was a €5.00M Series A investment on 27 March 2018, with the funding coming from WiSEED. Poietis operates in the Biotechnology, Pharmaceutical, and Wellness Beauty industries, aiming to revolutionize tissue engineering and cell therapy through bioprinting technology.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | €5.00M | 1 | WiSEED | 27 Mar 2018 |
Equity Crowdfunding | €2.50M | 2 | WiSEED, Cédric Delorme | 04 Jan 2016 |
No recent news or press coverage available for Poietis.